Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0522 SEK | -2.97% | +6.10% | -67.46% |
May. 24 | Chordate Medical Holding AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
May. 07 | Chordate Medical Receives Patent Approval in the US | CI |
Sales 2022 | 109K 10.31K | Sales 2023 | 1.75M 166K | Capitalization | 37.28M 3.54M |
---|---|---|---|---|---|
Net income 2022 | -27M -2.57M | Net income 2023 | -29M -2.76M | EV / Sales 2022 | 723 x |
Net cash position 2022 | 3.68M 349K | Net cash position 2023 | 8.46M 803K | EV / Sales 2023 | 16.5 x |
P/E ratio 2022 |
-2.89
x | P/E ratio 2023 |
-1.23
x | Employees | 3 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 73.38% |
1 day | -2.97% | ||
1 week | +6.10% | ||
1 month | -13.86% | ||
3 months | -40.27% | ||
6 months | -79.92% | ||
Current year | -67.46% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 14-10-31 | |
Director of Finance/CFO | 56 | 17-10-01 | |
Jan Hermansson
CTO | Chief Tech/Sci/R&D Officer | 68 | 11-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 69 | 14-05-31 | |
Gunilla Lundmark
BRD | Director/Board Member | 61 | 17-03-31 |
Chief Executive Officer | 63 | 14-10-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.0522 | -2.97% | 674,050 |
24-05-30 | 0.0538 | +5.08% | 413,955 |
24-05-29 | 0.0512 | -3.76% | 1,333,578 |
24-05-28 | 0.0532 | -6.34% | 701,204 |
24-05-27 | 0.0568 | +15.45% | 1,281,104 |
Delayed Quote Nasdaq Stockholm, May 31, 2024 at 11:29 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-67.46% | 2.42M | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- CMH Stock